KMPHARMACEUTICAL Co.,Ltd. Chairman Kang Il Mo group keeps 49.66% stake, fully repays a share-backed loan
AI summary · Not investment advice
Kang Il Mo and related parties kept their 49.66% stake in KMPHARMACEUTICAL Co.,Ltd. and fully repaid one share-backed loan. Pledged shares fell from 1,194,503 to 1,100,000; the remaining loan is due 2026.12.04.
Total under contracts
1,100,000 shares
Total 16.96% · previously 18.42%
Key facts
- Stake
- 49.66%Previous 49.66% · 0%p
- Reporting holder
- Kang Il Mo and 3 related parties
- Previous stake
- 49.66%
- Purpose of holding
- To influence management
- Relationship with issuer
- Largest shareholderChairman
- Report type
- Amendment
- Reason for report
- Partial repayment of share-backed loans
- Previous shares held
- 3,220,994 shares
- Shares held
- 3,220,994 shares
- Reason for amendment
- Partial repayment of share-backed loans
- Previous shares under major contracts
- 1,194,503 shares
- Shares under major contracts
- 1,100,000 shares
- Reporting obligation date
- Sep 30, 2026
Commentary
AI commentary · Not investment advice
What happened
Kang Il Mo, chairman and largest shareholder of KMPHARMACEUTICAL, reported that he fully repaid one of his loans backed by shares (share-backed loans), the one with a securities firm. No shares are pledged under that contract any more. The stake of Kang and his related parties (family and executives counted together) stayed at 49.66%.
In the company's terms
KMPHARMACEUTICAL has 6,485,675 voting shares in issue. The group holds 3,220,994 shares. Pledged shares fell from 1,194,503 (18.42%) to 1,100,000 (16.96%). The remaining pledge secures a KRW 3.4 billion bank loan at 4.34% interest.
What changes for shareholders
The remaining bank loan is due 2026.12.04.
Comments
No comments yet
Comments from shareholders will appear here.
Ad
Verify your holdings and catch the next disclosure
Verify the stocks you hold and get new disclosures as app alerts.

App design sample
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist
K